Smaller Germinal Centers Identified in Recurrent Tonsillitis

Share this content:
Smaller Germinal Centers Identified in Recurrent Tonsillitis
Smaller Germinal Centers Identified in Recurrent Tonsillitis

MONDAY, Feb. 11, 2019 (HealthDay News) -- Children with recurrent tonsillitis (RT) have smaller germinal centers, according to a study published in the Feb. 6 issue of Science Translational Medicine.

Jennifer M. Dan, M.D., Ph.D., from La Jolla Institute for Immunology in California, and colleagues performed phenotypic, genotypic, and functional studies on pediatric group A Streptococcus (GAS) RT and non-RT tonsils from two independent cohorts of children aged 5 to 18 years undergoing tonsillectomy.

The researchers identified smaller germinal centers in GAS RT tonsils, which had an underrepresentation of GAS-specific CD4+ germinal center T follicular helper (GC-TFH) cells. Children with RT exhibited reduced antibody responses to streptococcal pyrogenic exotoxin A (SpeA), an important GAS virulence factor. The investigators identified risk and protective human leukocyte antigen class II alleles for RT. SpeA-induced granzyme B production was observed in GC-TFH cells from RT tonsils, which could kill B cells and had the potential to hinder the germinal center response.

"We have 100+ years of experience with this disease but there really wasn't any good explanation why some kids suffer from recurrent strep throat," a coauthor said in a statement. "We think that this is the first solid evidence that there is an important immunological component as well as a genetic one which together contribute to recurrent strep throat. Let's try and build on it."

Two authors disclosed holding an international patent application: Diagnosis and treatment of infection involving killer T follicular helper cells, methods of preparation, and uses thereof.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA: Gout Drug Uloric Increases Risk of Death

FDA: Gout Drug Uloric Increases Risk of Death

Medication is associated with increased risk of heart-related death and death from all causes

Since Early 2000s, Overdose Death Rates Are Highest in U.S.

Since Early 2000s, Overdose Death Rates Are Highest ...

U.S. was not an outlier in terms of drug overdose mortality prior to the early 2000s

National Health Spending Set to Increase 5.5 Percent Annually

National Health Spending Set to Increase 5.5 Percent ...

Long-observed demographic and economic factors expected to drive growth in health spending

is free, fast, and customized just for you!




Already a member?

Sign In Now »